Research & Literature

Premenstrual syndrome: management and pathophysiology.

Imai A, Ichigo S, Matsunami K, Takagi H

Clinical and experimental obstetrics & gynecology 2015; (42(2)):123-8.

Premenstrual syndrome: A mini review.

Ryu A, Kim TH

Maturitas 2015; (82(4)):436-40.

Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.

Yonkers KA, Kornstein SG, Gueorguieva R, et al.

JAMA psychiatry 2015; (72(10)):1037-44 doi:10.1001/jamapsychiatry.2015.1472.

A Comprehensive Review of Treatment Options for Premenstrual Syndrome and Premenstrual Dysphoric Disorder.

Maharaj S, Trevino K

Journal of psychiatric practice 2015; (21(5)):334-50 doi:10.1097/PRA.0000000000000099.

GABAA Receptor-Modulating Steroids in Relation to Women's Behavioral Health.

Bäckström T, Bixo M, Strömberg J

Current psychiatry reports 2015; (17(11)):92 doi:10.1007/s11920-015-0627-4.

Daily symptom ratings for studying premenstrual dysphoric disorder: A review.

Bosman RC, Jung SE, Miloserdov K, et al.

Journal of affective disorders 2016; (189()):43-53.

Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.

Timby E, Bäckström T, Nyberg S, et al.

Psychopharmacology 2016; (233(11)):2109-2117 doi:10.1007/s00213-016-4258-1.

Association of premenstrual syndrome and premenstrual dysphoric disorder with bulimia nervosa and binge-eating disorder in a nationally representative epidemiological sample.

Nobles CJ, Thomas JJ, Valentine SE, et al.

The International journal of eating disorders 2016; (49(7)):641-50 doi:10.1002/eat.22539.

A symptom diary to assess severe premenstrual syndrome and premenstrual dysphoric disorder.

Janda C, Kues JN, Andersson G, et al.

Women & health 2017; (57(7)):837-854 doi:10.1080/03630242.2016.1206055.

Premenstrual Syndrome and Premenstrual Dysphoric Disorder.

Hofmeister S, Bodden S

American family physician 2016; (94(3)):236-40.

Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).

Eisenlohr-Moul TA, Girdler SS, Schmalenberger KM, et al.

The American journal of psychiatry 2017; (174(1)):51-59 doi:10.1176/appi.ajp.2016.15121510.

Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.

Schmidt PJ, Martinez PE, Nieman LK, et al.

The American journal of psychiatry 2017; (174(10)):980-989 doi:10.1176/appi.ajp.2017.16101113.

Premenstrual Dysphoric Disorder.

Lanza di Scalea T, Pearlstein T

The Psychiatric clinics of North America 2017; (40(2)):201-216 doi:10.1016/j.psc.2017.01.002.

Premenstrual disorders.

Yonkers KA, Simoni MK

American journal of obstetrics and gynecology 2018; (218(1)):68-74 doi:10.1016/j.ajog.2017.05.045.

Prevalence, Severity, and Correlates of Premenstrual Dysphoric Disorder Symptoms Among Women in the Arabian Peninsula.

Osman OT, Sabri S, Zoubeidi T, et al.

The primary care companion for CNS disorders 2017; (19(4)).

[Current Aspects of Premenstrual Dysphoric Disorder - A Review].

Beddig T, Kühner C

Psychotherapie, Psychosomatik, medizinische Psychologie 2017; (67(12)):504-513 doi:10.1055/s-0043-113816.

The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback.

Nguyen TV, Reuter JM, Gaikwad NW, et al.

Translational psychiatry 2017; (7(8)):e1193 doi:10.1038/tp.2017.146.

Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review.

Cerqueira RO, Frey BN, Leclerc E, Brietzke E

Archives of women's mental health 2017; (20(6)):713-719 doi:10.1007/s00737-017-0791-0.

Premenstrual Syndrome Diagnosis: A Comparative Study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST).

Henz A, Ferreira CF, Oderich CL, et al.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 2018; (40(1)):20-25 doi:10.1055/s-0037-1608672.

Eating disorders in premenstrual dysphoric disorder: a neuroendocrinological pathway to the pathogenesis and treatment of binge eating.

Dahlgren CL, Qvigstad E

Journal of eating disorders 2018; (6()):35 doi:10.1186/s40337-018-0222-2.

Internet-Based Cognitive-Behavioural Intervention for Women with Premenstrual Dysphoric Disorder: A Randomized Controlled Trial.

Weise C, Kaiser G, Janda C, et al.

Psychotherapy and psychosomatics 2019; (88(1)):16-29 doi:10.1159/000496237.

Surgical menopause in association with cognitive function and risk of dementia: A systematic review and meta-analysis.

Georgakis MK, Beskou-Kontou T, Theodoridis I, et al.

Psychoneuroendocrinology 2019; (106()):9-19 doi:10.1016/j.psyneuen.2019.03.013.

Premenstrual syndrome in Anand District, Gujarat: A cross-sectional survey.

Kamat SV, Nimbalkar A, Phatak AG, Nimbalkar SM

Journal of family medicine and primary care 2019; (8(2)):640-647 doi:10.4103/jfmpc.jfmpc_302_18.

Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change.

Eisenlohr-Moul TA, Kaiser G, Weise C, et al.

Psychological medicine 2020; (50(6)):964-972 doi:10.1017/S0033291719000849.

Premenstrual dysphoric disorder and associated factors among female health science students in Wollo University, Ethiopia, 2017/18.

Tsegaye D, Getachew Y

Maternal health, neonatology and perinatology 2019; (5()):8 doi:10.1186/s40748-019-0102-z.

Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives.

Rapkin AJ, Korotkaya Y, Taylor KC

Open access journal of contraception 2019; (10()):27-39 doi:10.2147/OAJC.S183193.

Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder.

Yen JY, Lin HC, Lin PC, et al.

International journal of environmental research and public health 2019; (16(22)) doi:10.3390/ijerph16224352.

A Pilot Randomized Treatment-Controlled Trial Comparing Vitamin B6 with Broad-Spectrum Micronutrients for Premenstrual Syndrome.

Retallick-Brown H, Blampied N, Rucklidge JJ

Journal of alternative and complementary medicine (New York, N.Y.) 2020; (26(2)):88-97 doi:10.1089/acm.2019.0305.

Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study.

Yen JY, Lin PC, Huang MF, et al.

International journal of environmental research and public health 2020; (17(3)) doi:10.3390/ijerph17030988.

Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle.

Hantsoo L, Epperson CN

Neurobiology of stress 2020; (12()):100213 doi:10.1016/j.ynstr.2020.100213.

Psychometric Properties of a DSM-5-Based Screening Tool for Women's Perceptions of Premenstrual Symptoms.

Richards MA, Oinonen KA

Psychological reports 2022; (125(2)):1186-1217 doi:10.1177/0033294120979696.

Premenstrual syndrome, a common but underrated entity: review of the clinical literature

Dilbaz B, Aksan A

Journal of the Turkish German Gynecological Association 2021; (22(2)):139-148 doi:10.4274/jtgga.galenos.2021.2020.0133.

The reliability and validity of the Japanese version of the Daily Record of Severity of Problems (J-DRSP) and Development of a Short-Form version (J-DRSP (SF)) to assess symptoms of premenstrual syndrome among Japanese women.

Ikeda Y, Egawa M, Okamoto K, et al.

BioPsychoSocial medicine 2021; (15(1)):6 doi:10.1186/s13030-021-00208-z.

Patient Experiences of Health Care Providers in Premenstrual Dysphoric Disorder: Examining the Role of Provider Specialty.

Hantsoo L, Sajid H, Murphy L, et al.

Journal of women's health (2002) 2022; (31(1)):100-109 doi:10.1089/jwh.2020.8797.

Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in India: A systematic review and meta-analysis.

Dutta A, Sharma A

Health promotion perspectives 2021; (11(2)):161-170 doi:10.34172/hpp.2021.20.

Suicidal Risk in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Systematic Review and Meta-Analysis.

Prasad D, Wollenhaupt-Aguiar B, Kidd KN, et al.

Journal of women's health (2002) 2021; (30(12)):1693-1707 doi:10.1089/jwh.2021.0185.

Premenstrual Exacerbations of Mood Disorders: Findings and Knowledge Gaps.

Kuehner C, Nayman S

Current psychiatry reports 2021; (23(11)):78 doi:10.1007/s11920-021-01286-0.

Effects of early estradiol valerate administration on bone turnover markers in surgically induced menopausal women.

Vatrasresth J, Suwan A, Panyakhamlerd K

BMC women's health 2021; (21(1)):363 doi:10.1186/s12905-021-01508-w.

The Influence of Depression on Biased Diagnosis of Premenstrual Syndrome and Premenstrual Dysphoric Disorder by the PSST Inventory.

Śliwerski A, Koszałkowska K

Life (Basel, Switzerland) 2021; (11(11)) doi:10.3390/life11111278.

Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder.

Wikman A, Sacher J, Bixo M, et al.

BMC women's health 2022; (22(1)):35 doi:10.1186/s12905-022-01612-5.

Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder.

Eisenlohr-Moul T, Divine M, Schmalenberger K, et al.

BMC psychiatry 2022; (22(1)):199 doi:10.1186/s12888-022-03851-0.

Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome.

Tiranini L, Nappi RE

Faculty reviews 2022; (11()):11 doi:10.12703/r/11-11.

Premenstrual syndrome predicts alcohol craving in women with substance use disorders.

Qurishi R, Drenth JPH, De Jong CAJ

Women & health 2022; (62(5)):430-438 doi:10.1080/03630242.2022.2084212.

Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: A systematic review and meta-analysis of randomised trials.

Reilly TJ, Wallman P, Clark I, et al.

Journal of psychopharmacology (Oxford, England) 2023; (37(3)):261-267 doi:10.1177/02698811221099645.

Premenstrual syndrome and premenstrual dysphoric disorder

Kovács Z, Hegyi G, Szőke H

Orvosi hetilap 2022; (163(26)):1023-1031 doi:10.1556/650.2022.32496.

The pharmacotherapeutic management of premenstrual dysphoric disorder.

Ciccone N, Kovacheff MB, Frey BN

Expert opinion on pharmacotherapy 2023; (24(1)):145-151 doi:10.1080/14656566.2022.2114345.

Management of Premenstrual Dysphoric Disorder: A Scoping Review.

Carlini SV, Lanza di Scalea T, McNally ST, et al.

International journal of women's health 2022; (14()):1783-1801 doi:10.2147/IJWH.S297062.

Increase in Serotonin Transporter Binding in Patients With Premenstrual Dysphoric Disorder Across the Menstrual Cycle: A Case-Control Longitudinal Neuroreceptor Ligand Positron Emission Tomography Imaging Study.

Sacher J, Zsido RG, Barth C, et al.

Biological psychiatry 2023; (93(12)):1081-1088 doi:10.1016/j.biopsych.2022.12.023.

Towards understanding the biology of premenstrual dysphoric disorder: From genes to GABA.

Hantsoo L, Payne JL

Neuroscience and biobehavioral reviews 2023; (149()):105168 doi:10.1016/j.neubiorev.2023.105168.

Prophylactic mastectomy and bilateral salpingo-oophorectomy in patients with breast cancer: a systematic review of postsurgical sexual function and menopausal hormone therapy symptom mitigation.

Morgan O, Belda R, Schnur J, et al.

Sexual medicine reviews 2023; (12(1)):3-13 doi:10.1093/sxmrev/qead020.

Does Symptom-Onset Treatment With Sertraline Improve Functional Impairment for Individuals With Premenstrual Dysphoric Disorder?: A Randomized Controlled Trial.

Yonkers KA, Altemus M, Gilstad-Hayden K, et al.

Journal of clinical psychopharmacology 2023; (43(4)):320-325 doi:10.1097/JCP.0000000000001700.

Oral contraceptives containing drospirenone for premenstrual syndrome.

Ma S, Song SJ

The Cochrane database of systematic reviews 2023; (6()):CD006586 doi:10.1002/14651858.CD006586.pub5.

Significance and Interrelationship of the Symptoms Listed in the DSM Criteria for Premenstrual Dysphoric Disorder.

Studer E, Nilsson S, Westman A, et al.

Psychiatric research and clinical practice 2023; (5(3)):105-113 doi:10.1176/appi.prcp.20220007.

Premature ovarian insufficiency, early menopause, and induced menopause.

Hamoda H, Sharma A

Best practice & research. Clinical endocrinology & metabolism 2024; (38(1)):101823 doi:10.1016/j.beem.2023.101823.

[Premenstrual dysphoric disorder (PMDD): Drug and psychotherapeutique management, a literature review].

Marais-Thomas H, Chapelle F, de Vaux-Boitouzet V, Bouvet C

L'Encephale 2024; (50(2)):211-232 doi:10.1016/j.encep.2023.08.007.

Management of Premenstrual Disorders: ACOG Clinical Practice Guideline No. 7.

Obstetrics and gynecology 2023; (142(6)):1516-1533 doi:10.1097/AOG.0000000000005426.

Premenstrual Syndrome and Premenstrual Dysphoric Disorder's Impact on Quality of Life, and the Role of Physical Activity.

Liguori F, Saraiello E, Calella P

Medicina (Kaunas, Lithuania) 2023; (59(11)) doi:10.3390/medicina59112044.

Diagnostic validity of premenstrual dysphoric disorder: revisited.

Naik SS, Nidhi Y, Kumar K, Grover S

Frontiers in global women's health 2023; (4()):1181583 doi:10.3389/fgwh.2023.1181583.

The multifactorial aetiology and management of premenstrual dysphoric disorder with leuprorelin acetate.

Dunphy L, Boyle S, Wood F

BMJ case reports 2023; (16(12)) doi:10.1136/bcr-2023-258343.

Premenstrual disorders and PMDD - a review.

Cary E, Simpson P

Best practice & research. Clinical endocrinology & metabolism 2024; (38(1)):101858 doi:10.1016/j.beem.2023.101858.

The prevalence of premenstrual dysphoric disorder: Systematic review and meta-analysis.

Reilly TJ, Patel S, Unachukwu IC, et al.

Journal of affective disorders 2024; (349()):534-540 doi:10.1016/j.jad.2024.01.066.

Menstrual and psychosocial characteristics associated with high-risk of premenstrual dysphoric disorder among university students: a cross-sectional study.

Lee JJ, Wang T, Park J, et al.

Women & health 2024; (64(2)):153-164 doi:10.1080/03630242.2024.2304899.

Factors associated with suicide risk in young women with premenstrual dysphoric disorder: a population-based study.

Machado FZ, da Mota MSS, Dos Santos EP, et al.

Trends in psychiatry and psychotherapy 2025; (47()):e20230718 doi:10.47626/2237-6089-2023-0718.

[Premenstrual syndrome and premenstrual dysphoric disorder-Overview on pathophysiology, diagnostics and treatment].

Haußmann J, Goeckenjan M, Haußmann R, Wimberger P

Der Nervenarzt 2024; (95(3)):268-274 doi:10.1007/s00115-024-01625-5.

Management of Premenstrual Dysphoric Disorder: A Scoping Review.

Carlini SV, Lanza di Scalea T, McNally ST, et al.

Focus (American Psychiatric Publishing) 2024; (22(1)):81-96 doi:10.1176/appi.focus.23021035.

Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder.

Jespersen C, Lauritsen MP, Frokjaer VG, Schroll JB

The Cochrane database of systematic reviews 2024; (8()):CD001396 doi:10.1002/14651858.CD001396.pub4.

Understanding premenstrual exacerbation: navigating the intersection of the menstrual cycle and psychiatric illnesses.

Lin J, Nunez C, Susser L, Gershengoren L

Frontiers in psychiatry 2024; (15()):1410813 doi:10.3389/fpsyt.2024.1410813.

The experiences and psychological impact of living with premenstrual disorders: a systematic review and thematic synthesis.

Brown D, Smith DM, Osborn E, Wittkowski A

Frontiers in psychiatry 2024; (15()):1440690 doi:10.3389/fpsyt.2024.1440690.

Barriers to Diagnosis and Treatment for Premenstrual Dysphoric Disorder (PMDD): A Scoping Review.

Nayak A, Wood SN, Hantsoo L

Reproductive sciences (Thousand Oaks, Calif.) 2025; (32(6)):1757-1767 doi:10.1007/s43032-025-01861-3.

Premenstrual Dysphoric Disorder: A Cross-Sectional Study on Prevalence and Awareness Among Medical Students.

Babour RR, Alharbi SA, Alzahrani SM, et al.

Cureus 2025; (17(3)):e80917 doi:10.7759/cureus.80917.

Perceived occupational competence and value among university students with premenstrual dysphoric disorder.

Pekçetin S, Özdinç S, Ata H, et al.

The British journal of occupational therapy 2022; (85(5)):327-331 doi:10.1177/03080226211020991.

Premenstrual exacerbation of psychiatric symptoms: from misdiagnosis to management.

Kulkarni J, Mu E

The British journal of psychiatry : the journal of mental science 2025; (226(6)):346-348 doi:10.1192/bjp.2024.295.

Gonadotropin-releasing hormone (GnRH) analogues for premenstrual syndrome (PMS).

Naheed B, Kuiper JH, O'Mahony F, O'Brien PM

The Cochrane database of systematic reviews 2025; (6()):CD011330 doi:10.1002/14651858.CD011330.pub2.

Increased risk of provisional premenstrual dysphoric disorder (PMDD) among females with attention-deficit hyperactivity disorder (ADHD): cross-sectional survey study.

Broughton T, Lambert E, Wertz J, Agnew-Blais J

The British journal of psychiatry : the journal of mental science 2025; (226(6)):410-417 doi:10.1192/bjp.2025.104.

Trajectories and dimensional phenotypes of depressive symptoms throughout pregnancy and postpartum in relation to prior premenstrual symptoms.

Schleimann-Jensen E, Sundström-Poromaa I, Meltzer-Brody S, et al.

The British journal of psychiatry : the journal of mental science 2025; (226(6)):401-409 doi:10.1192/bjp.2025.38.

Premenstrual syndrome and premenstrual dysphoric disorder: Symptoms severity, functional impairment, and associated factors: A Saudi cross-sectional study.

Sayed SH, Al-Mohaithef M, Ibrahim EM, Elsayed EA

Journal of education and health promotion 2025; (14()):185 doi:10.4103/jehp.jehp_708_24.

Transcription of GABAA receptor subunits in circulating monocytes and association to emotional brain function in premenstrual dysphoric disorder.

Stiernman L, Comasco E, Johansson M, Bixo M

Translational psychiatry 2025; (15(1)):255 doi:10.1038/s41398-025-03465-6.

Cardiovascular Consequences of Premature Menopause.

Bast JA, Olubi O, Le DE, et al.

Current cardiology reports 2025; (27(1)):126.

Menstruation-Related Diseases, Work Performance, and Oral Contraceptive: Nationwide Online Survey.

Maeda Y, Tabuchi T, Fujiwara T

Journal of occupational and environmental medicine 2025; (67(12)):1014-1019 doi:10.1097/JOM.0000000000003533.

Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings.

Wei SM, Wakim P, Martinez PE, et al.

The American journal of psychiatry 2025; (182(10)):922-934 doi:10.1176/appi.ajp.20240596.

Patient Perspectives of Healthcare for Premenstrual Dysphoric Disorder in Australia: A Mixed-Methods Study.

Border G, Miller YD

Health services insights 2026; (19()):11786329251409981 doi:10.1177/11786329251409981.

Medical gas-lighting, diagnostic odyssey and self-advocacy among women with premenstrual dysphoric disorder from nine countries.

Mosalisa M, Roomaney R

Journal of health psychology 2026; (31(8)):3227-3240 doi:10.1177/13591053251401286.

Updated insight into the pathophysiology of premenstrual dysphoric disorder and therapeutic approaches.

Sultana J, Sharma AR, Soha ST, et al.

Journal of affective disorders 2026; (405()):121593 doi:10.1016/j.jad.2026.121593.

Gold-standard evidence and best practice guidance for menstrual cycle-informed clinical care: An overview for clinicians.

Lambert ER, Nolan LN, Schmalenberger KM

The British journal of clinical psychology 2026; doi:10.1111/bjc.70066.

Women's experiences of living with premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD): A scoping review.

Haidarieh-Zadeh C, Morgan J, Gale L, Dibley L

Health care for women international 2026; (47(5)):499-522 doi:10.1080/07399332.2026.2671885.

Prevalence and severity of premenstrual tension syndrome and its impact on academic performance among female university students in Bangladesh: a cross-sectional study.

Lemon MMH, Ahmed S, Khatun MK, Rana MS

BMC public health 2026; (26(1)).

Prospective daily evidence of cyclic suicidality and self-harm in premenstrual disorders.

Ly M, Zorzini G, Wahl T, et al.

Psychoneuroendocrinology 2026; (191()):107949 doi:10.1016/j.psyneuen.2026.107949.

Hormone replacement therapy in gynecologic cancer survivors: bridging the gap between evidence and clinical practice.

Gil-Ibáñez B, Luzarraga Aznar A, Barretina-Ginesta MP, et al.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2026; 104881 doi:10.1016/j.ijgc.2026.104881.

Breaking the Cycle: A Case of Delayed Diagnosis and Sustained Remission Following Definitive Surgical Treatment of Premenstrual Dysphoric Disorder (PMDD).

Deaton DJ, Deaton SL

Case reports in psychiatry 2026; (2026()):8233699 doi:10.1155/crps/8233699.

Age at Iatrogenic Menopause and Cardiovascular Morbidity and Mortality: A Systematic Review and Meta-Analysis.

Armeni E, Erkan IBO, Kempegowda P

JAMA network open 2026; (9(10)):e2637545 doi:10.1001/jamanetworkopen.2026.37545.